Mission Therapeutics

Mission Therapeutics, located in Cambridgeshire, United Kingdom, is an early-stage drug development company targeting the ubiquitin pathway for the treatment of kidney disease, neurodegenerative disease, rare mitochondrial diseases, and fibrosis.